Filter
Reset all

Subjects

Content Types

Countries

AID systems

API

Certificates

Data access

Data access restrictions

Database access

Database access restrictions

Database licenses

Data licenses

Data upload

Data upload restrictions

Enhanced publication

Institution responsibility type

Institution type

Keywords

Metadata standards

PID systems

Provider types

Quality management

Repository languages

Software

Repository types

Versioning

  • * at the end of a keyword allows wildcard searches
  • " quotes can be used for searching phrases
  • + represents an AND search (default)
  • | represents an OR search
  • - represents a NOT operation
  • ( and ) implies priority
  • ~N after a word specifies the desired edit distance (fuzziness)
  • ~N after a phrase specifies the desired slop amount
  • 1 (current)
Found 7 result(s)
Content type(s)
Country
The GISAID Initiative promotes the international sharing of all influenza virus sequences, related clinical and epidemiological data associated with human viruses, and geographical as well as species-specific data associated with avian and other animal viruses, to help researchers understand how the viruses evolve, spread and potentially become pandemics. *** GISAID does so by overcoming disincentives/hurdles or restrictions, which discourage or prevented sharing of influenza data prior to formal publication. *** The Initiative ensures that open access to data in GISAID is provided free-of-charge and to everyone, provided individuals identify themselves and agree to uphold the GISAID sharing mechanism governed through its Database Access Agreement. GISAID calls on all users to agree to the basic premise of upholding scientific etiquette, by acknowledging the originating laboratories providing the specimen and the submitting laboratories who generate the sequence data, ensuring fair exploitation of results derived from the data, and that all users agree that no restrictions shall be attached to data submitted to GISAID, to promote collaboration among researchers on the basis of open sharing of data and respect for all rights and interests.
The NCEAS Data Repository contains information about the research data sets collected and collated as part of NCEAS' funded activities. Information in the NCEAS Data Repository is concurrently available through the Knowledge Network for Biocomplexity (KNB), an international data repository. A number of the data sets were synthesized from multiple data sources that originated from the efforts of many contributors, while others originated from a single. Datasets can be found at KNB repository https://knb.ecoinformatics.org/data , creator=NCEAS
Content type(s)
The Antibody Registry supports the RRID Initiative and exists to give researchers a way to universally identify antibodies used in publications. The registry lists many commercial antibodies from over 200 vendors, which have been assigned a unique identifier and over 2000 individual laboratories. If the antibody that you are using does not appear in the list, an entry can be made by filling in as little as 2 pieces of information: the catalog number and the url of the vendor where our curators can find information and material data sheets.
The main goal of the CLUES-project is to provide constrained simulations of the local universe designed to be used as a numerical laboratory of the current paradigm. The simulations will be used for unprecedented analysis of the complex dark matter and gasdynamical processes which govern the formation of galaxies. The predictions of these experiments can be easily compared with the detailed observations of our galactic neighborhood. Some of the CLUES data is now publicly available via the CosmoSim database (https://www.cosmosim.org/). This includes AHF halo catalogues from the Box 64, WMAP3 resimulations of the Local Group with 40963 particle resolution.
The Antimicrobial Peptide Database (APD) was originally created by a graduate student, Zhe Wang, as his master's thesis in the laboratory of Dr. Guangshun Wang. The project was initiated in 2002 and the first version of the database was open to the public in August 2003. It contained 525 peptide entries, which can be searched in multiple ways, including APD ID, peptide name, amino acid sequence, original location, PDB ID, structure, methods for structural determination, peptide length, charge, hydrophobic content, antibacterial, antifungal, antiviral, anticancer, and hemolytic activity. Some results of this bioinformatics tool were reported in the 2004 database paper. The peptide data stored in the APD were gleaned from the literature (PubMed, PDB, Google, and Swiss-Prot) manually in over a decade.
Content type(s)
The Australian New Zealand Clinical Trials Registry (ANZCTR) is an online register of clinical trials being undertaken in Australia, New Zealand and elsewhere. The ANZCTR includes trials from the full spectrum of therapeutic areas of pharmaceuticals, surgical procedures, preventive measures, lifestyle, devices, treatment and rehabilitation strategies and complementary therapies.
Country
ONC, an initiative of the University of Victoria (UVic), is Canada’s national ocean observatory. ONC has installations and local partnerships with Indigenous and coastal communities on all three coasts, along with an Antarctic station, and more than 32,000 users of its scientific data around the world. The ocean data collected by ONC’s cabled, mobile, and community-led observatories are accessible to all through ONC’s Oceans 3.0 data portal. By embracing multiple ways of knowing, ONC supports ocean health through enhanced coastal monitoring, science that promotes ocean resilience and a sustainable blue economy, data that inform maritime safety, and education programs that strengthen our connection to, and stewardship of, the ocean. ONC is committed to: (1) advancing ocean observing; (2) delivering world-class data and data products; (3) enabling ocean-based solutions for climate change mitigation and coastal resilience.